Volume 87, Issue 1, Pages (January 2015)

Slides:

Advertisements

Similar presentations

LDL cholesterol in CKD—to treat or not to treat?

Advertisements

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Shining light on vitamin D trials in chronic kidney disease

Kidney transplantation in a low-resource setting: Nigeria experience

Prehypertension and chronic kidney disease: the ox or the plow?

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

John P. Middleton, Patrick H. Pun Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Need for better diabetes treatment for improved renal outcome

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Metformin and other antidiabetic agents in renal failure patients

End-stage renal disease in living kidney donors

Volume 69, Issue 2, Pages (January 2006)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 63, Issue 2, Pages (February 2003)

Comorbidity and confounding in end-stage renal disease

Volume 82, Issue 3, Pages (August 2012)

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

Volume 63, Issue 1, Pages (January 2003)

Volume 77, Issue 2, Pages (January 2010)

Study of Heart and Renal Protection (SHARP)

LDL cholesterol in CKD—to treat or not to treat?

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 73, Issue 12, Pages (June 2008)

Does reducing salt intake increase cardiovascular mortality?

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Volume 87, Issue 1, Pages (January 2015)

Volume 76, Issue 8, Pages (October 2009)

The kidney, a cardiovascular risk marker, and a new target for therapy

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

Cardiovascular risk factors in chronic kidney disease

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 85, Issue 5, Pages (May 2014)

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Volume 78, Issue 8, Pages (October 2010)

Volume 73, Issue 9, Pages (May 2008)

Cardiovascular risk assessment in kidney transplantation

Volume 64, Issue 2, Pages (August 2003)

Fish oil for prevention of sudden death in hemodialysis patients?

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 87, Issue 1, Pages (January 2015)

Volume 80, Issue 10, Pages (November 2011)

Volume 77, Issue 1, Pages (January 2010)

American Indian heritage and risk factors for renal injury

Is it the low-protein diet or simply the salt restriction?

Volume 67, Issue 5, Pages (May 2005)

Renal replacement therapy in Latin America

Volume 75, Issue 7, Pages (April 2009)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Membranous nephropathy: recent travels and new roads ahead

Antioxidant therapy in hemodialysis patients: a systematic review

Volume 83, Issue 3, Pages (March 2013)

Presentation transcript:

Volume 87, Issue 1, Pages 20-30 (January 2015) Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes Mark E. Molitch, Amanda I. Adler, Allan Flyvbjerg, Robert G. Nelson, Wing-Yee So, Christoph Wanner, Bertram L. Kasiske, David C. Wheeler, Dick de Zeeuw, Carl E. Mogensen Kidney International Volume 87, Issue 1, Pages 20-30 (January 2015) DOI: 10.1038/ki.2014.128 Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 1 Approaches to improving outcomes related to diabetic kidney disease. The best approach to prevent diabetic kidney disease is to prevent diabetes itself. However, once diabetes occurs glycemic control may prevent/delay the development of diabetic kidney disease. In those patients who develop diabetic kidney disease, glycemic control, blood pressure control, and RAAS inhibition are all important in delaying/decreasing progression to ESRD and glycemic control, blood pressure control, and lipid management are all important in delaying/decreasing the development of CVD. CVD, cardiovascular disease; ESRD, end-stage renal disease; RAAS, renin–angiotensin–aldosterone system. White arrows denote potential preventive measures. Kidney International 2015 87, 20-30DOI: (10.1038/ki.2014.128) Copyright © 2015 International Society of Nephrology Terms and Conditions